|
ES2248822T3
(es)
|
1995-09-15 |
2006-03-16 |
Dale N. Gerding |
Procedimientos y composiciones para la prevencion y el tratamiento de enfermedades asociadas al clostridium difficile.
|
|
AUPQ899700A0
(en)
*
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
US20090197249A1
(en)
|
2004-11-01 |
2009-08-06 |
George Mason University |
Compositions and methods for diagnosing colon disorders
|
|
KR101260533B1
(ko)
*
|
2005-03-03 |
2013-05-06 |
가부시키가이샤 메이지 |
면역기능 조정제
|
|
US9603876B2
(en)
|
2008-09-25 |
2017-03-28 |
New York University |
Compositions and methods for restoring gastrointestinal microbiota following antibiotic treatment
|
|
GB0916335D0
(en)
*
|
2009-09-17 |
2009-10-28 |
Martin W J |
Medicaments
|
|
DK3564357T3
(da)
*
|
2010-02-01 |
2022-06-20 |
Rebiotix Inc |
Bakterieterapi mod clostridium difficile colitis
|
|
WO2011151941A1
(ja)
|
2010-06-04 |
2011-12-08 |
国立大学法人東京大学 |
制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
|
|
EP3424515A3
(en)
|
2010-08-04 |
2019-06-19 |
Thomas Julius Borody |
Stool collection devices and methods for using them
|
|
US9386793B2
(en)
|
2010-08-20 |
2016-07-12 |
New York University |
Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota
|
|
MX359082B
(es)
|
2011-05-23 |
2018-09-11 |
Washington State Univ Research Foundation |
Uso de agentes estabilizantes de pigmento fotosintético para regular la maduración y calidad de frutas y vegetales.
|
|
US20140363397A1
(en)
|
2011-09-14 |
2014-12-11 |
Queen's University At Kingston |
Method for treatment of disorders of the gastrointestinal system
|
|
ES2993669T3
(en)
|
2011-12-01 |
2025-01-03 |
Univ Tokyo |
Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
|
|
EP2836224A4
(en)
|
2012-02-29 |
2015-12-16 |
Ethicon Endo Surgery Inc |
COMPOSITIONS OF BIOZOOSE AND RELATED METHODS
|
|
JP6201982B2
(ja)
|
2012-03-30 |
2017-09-27 |
味の素株式会社 |
糖尿病誘起細菌
|
|
US10130665B2
(en)
|
2012-05-18 |
2018-11-20 |
Genome Research Limited |
Method for identifying bacteria for bacteriotherapy
|
|
CN102743420A
(zh)
|
2012-06-06 |
2012-10-24 |
上海交通大学 |
改善肠道菌群结构的方法及应用
|
|
SG11201503966PA
(en)
|
2012-11-23 |
2015-06-29 |
Seres Health Inc |
Synergistic bacterial compositions and methods of production and use thereof
|
|
US8906668B2
(en)
|
2012-11-23 |
2014-12-09 |
Seres Health, Inc. |
Synergistic bacterial compositions and methods of production and use thereof
|
|
JP2016509003A
(ja)
|
2013-02-04 |
2016-03-24 |
セレス セラピューティクス インコーポレイテッド |
組成物および方法
|
|
AU2014239883B2
(en)
*
|
2013-03-14 |
2019-01-17 |
Therabiome, Llc |
Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
|
|
EP2971148A4
(en)
|
2013-03-14 |
2016-08-17 |
Seres Therapeutics Inc |
METHODS OF DETECTING PATHOGENS AND ENRICHING FROM MATERIALS AND COMPOSITIONS
|
|
WO2014145958A2
(en)
|
2013-03-15 |
2014-09-18 |
Seres Health, Inc. |
Network-based microbial compositions and methods
|
|
WO2014150094A1
(en)
|
2013-03-15 |
2014-09-25 |
University Of Florida Research Foundation, Inc. |
Butyrogenic bacteria as probiotics to treat clostridium difficile
|
|
WO2015006355A2
(en)
|
2013-07-09 |
2015-01-15 |
Puretech Ventures, Llc |
Compositions containing combinations of bioactive molecules derived from microbiota for treatment of disease
|
|
CA2926466C
(en)
|
2013-10-03 |
2021-11-16 |
Frederic Bushman |
Compositions comprising a defined microbiome and methods of use thereof
|
|
CN105979952B
(zh)
|
2013-11-25 |
2022-04-08 |
赛里斯治疗公司 |
协同细菌组合物以及其制造方法和用途
|
|
US9956282B2
(en)
|
2013-12-16 |
2018-05-01 |
Seres Therapeutics, Inc. |
Bacterial compositions and methods of use thereof for treatment of immune system disorders
|
|
AU2015244700B2
(en)
|
2014-04-10 |
2020-08-27 |
Riken |
Compositions and methods for induction of Th17 cells
|
|
EP3134509B1
(en)
|
2014-04-23 |
2026-01-21 |
Cornell University |
Modulation of fat storage in a subject by altering population levels of christensenellaceae in the gi tract
|
|
US20170087196A1
(en)
|
2014-05-19 |
2017-03-30 |
Memorial Sloan-Kettering Cancer Center |
Methods and compositions for reducing clostridium difficile infection
|
|
CA2964480A1
(en)
|
2014-10-31 |
2016-05-06 |
Whole Biome Inc. |
Methods and compositions relating to microbial treatment and diagnosis of disorders
|
|
MA41020A
(fr)
|
2014-11-25 |
2017-10-03 |
Evelo Biosciences Inc |
Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
|
|
WO2016086161A1
(en)
|
2014-11-25 |
2016-06-02 |
Memorial Sloan-Kettering Cancer Center |
Intestinal microbiota and gvhd
|
|
BR112017024264B1
(pt)
|
2015-05-14 |
2022-07-12 |
Crestovo Holdings Llc |
Composições para transplante de flora fecal e métodos de preparação e utilização das mesmas, e dispositivos para sua administração
|
|
EA201792547A1
(ru)
|
2015-05-21 |
2018-04-30 |
Иеда Рисеч Энд Девелопмент Ко. Лтд. |
Популяции бактерий для стимуляции состояния здоровья
|
|
WO2016201053A1
(en)
|
2015-06-09 |
2016-12-15 |
Regents Of The University Of Minnesota |
Methods for detecting risk of having a bloodstream infection and compositions for reducing the risk
|
|
MA41060B1
(fr)
|
2015-06-15 |
2019-11-29 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
NZ737752A
(en)
|
2015-06-15 |
2022-02-25 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
SMT201900588T1
(it)
|
2015-06-15 |
2019-11-13 |
4D Pharma Res Limited |
Blautia stercoris e wexlerae per uso nel trattamento di malattie infiammatorie ed autoimmuni
|
|
MA41010B1
(fr)
|
2015-06-15 |
2020-01-31 |
4D Pharma Res Ltd |
Compositions comprenant des souches bactériennes
|
|
WO2016203221A1
(en)
|
2015-06-15 |
2016-12-22 |
4D Pharma Research Limited |
Compositions comprising bacterial strains
|
|
JP2018519295A
(ja)
|
2015-06-22 |
2018-07-19 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
粘膜固有層調節性ｔ細胞の誘導
|
|
EP3319619A4
(en)
|
2015-07-08 |
2019-01-02 |
Seres Therapeutics, Inc. |
Methods of treating colitis
|
|
EP3341000A4
(en)
|
2015-08-24 |
2019-02-20 |
Nubyiota LLC |
SYSTEMS AND METHOD FOR TREATING DYSBIOSIS WITH BACTERIAL POPULATIONS FROM FECALIA
|
|
MX2018005107A
(es)
|
2015-10-26 |
2018-08-09 |
Crestovo Holdings Llc |
Composiciones y metodos para la terapia relacionada con la microbiota fecal.
|
|
CN108513545B
(zh)
|
2015-11-20 |
2020-11-03 |
4D制药研究有限公司 |
包含细菌菌株的组合物
|
|
GB201520497D0
(en)
|
2015-11-20 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520638D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
GB201520631D0
(en)
|
2015-11-23 |
2016-01-06 |
4D Pharma Res Ltd |
Compositions comprising bacterial strains
|
|
PL3380108T3
(pl)
|
2015-11-24 |
2023-03-27 |
Seres Therapeutics, Inc. |
Zaprojektowane kompozycje bakteryjne
|
|
ME03487B
(me)
|
2016-03-04 |
2020-01-20 |
4D Pharma Plc |
Kompozicije koje sadrže blautia bakterijske sojeve za liječenje visceralne hipersenzitivnosti
|
|
US20170290889A1
(en)
|
2016-04-11 |
2017-10-12 |
New York University |
Methods and compositions for treating dysbiosis and gastrointestinal and inflammatory disorders
|
|
CA3226196A1
(en)
|
2016-06-14 |
2017-12-21 |
Vedanta Biosciences, Inc. |
Treatment of clostridium difficile infection
|
|
US9999641B2
(en)
|
2016-06-14 |
2018-06-19 |
Vedanta Biosciences, Inc. |
Treatment of clostridium difficile infection
|
|
CN109562147B
(zh)
|
2016-06-28 |
2023-09-01 |
特里瓦生物制剂有限公司 |
保护微生物组免受口服抗生素
|
|
US12176071B2
(en)
*
|
2016-10-26 |
2024-12-24 |
The Joan & Irwin Jacobs Technion-Cornell Institute |
Systems and methods for ultra-fast identification and abundance estimates of microorganisms using a kmer-depth based approach and privacy-preserving protocols
|
|
BR112020023933A2
(pt)
|
2018-05-24 |
2021-04-27 |
Seres Therapeutics, Inc. |
composições bacterianas projetadas e usos destas
|
|
AU2019321681A1
(en)
*
|
2018-08-17 |
2021-02-25 |
Vedanta Biosciences, Inc. |
Methods of decreasing dysbiosis and restoring a microbiome
|
|
WO2022159711A1
(en)
|
2021-01-21 |
2022-07-28 |
Vedanta Biosciences, Inc. |
Compositions and methods for treating hepatic encephalopathy
|